Profil
Manabu Nakamura is currently Managing Partner & CEO at Shinsei Capital Partners Ltd since 2018, Director at Alphanavi Pharma KK, and Outside Director at Chordia Therapeutics, Inc. since 2024.
Formerly, Mr. Nakamura was Outside Director at Chordia Therapeutics, Inc. from 2019 to 2021.
Postes actifs de Manabu Nakamura
| Sociétés | Poste | Début |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/11/2024 |
Shinsei Capital Partners Ltd
Shinsei Capital Partners Ltd Investment ManagersFinance Shinsei Capital Partners is an active manager that provides financing for seed stage, early stage, later stage and pre-IPO stage capital requirements. The firm targets companies operating in the field of digital health and life sciences. It targets companies operating in Japan. | Directeur Général | 01/01/2018 |
Alphanavi Pharma KK
Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Manufactures drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Manabu Nakamura
| Sociétés | Poste | Fin |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/11/2021 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Chordia Therapeutics, Inc.
Chordia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures oncology drugs | Health Technology |
Alphanavi Pharma KK
Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Manufactures drugs | Health Technology |
Shinsei Capital Partners Ltd
Shinsei Capital Partners Ltd Investment ManagersFinance Shinsei Capital Partners is an active manager that provides financing for seed stage, early stage, later stage and pre-IPO stage capital requirements. The firm targets companies operating in the field of digital health and life sciences. It targets companies operating in Japan. | Finance |
















